These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8780141)

  • 1. SGPG in ALS.
    Steck A; Gabriel JM; Antoine JC; Michel D
    Neurology; 1996 Apr; 46(4):1195-6. PubMed ID: 8780141
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-sulfoglucuronyl paragloboside IgM antibodies in amyotrophic lateral sclerosis.
    Ben Younes-Chennoufi A; Rozier A; Dib M; Bouche P; Lacomblez L; Mombo N; Ben Simon G; Yu RK; Baumann N; Meininger V
    J Neuroimmunol; 1995 Mar; 57(1-2):111-5. PubMed ID: 7706428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevation of serum soluble E-selectin and antisulfoglucuronyl paragloboside antibodies in amyotrophic lateral sclerosis.
    Ikeda J; Kohriyama T; Nakamura S
    Eur J Neurol; 2000 Sep; 7(5):541-7. PubMed ID: 11054140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autopsy-proven amyotrophic lateral sclerosis, Waldenström's macroglobulinemia, and antibodies to sulfated glucuronic acid paragloboside.
    Rowland LP; Sherman WL; Hays AP; Lange DJ; Latov N; Trojaborg W; Younger DS
    Neurology; 1995 Apr; 45(4):827-9. PubMed ID: 7723980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALS and paraproteinemia.
    Tavolato B
    Neurology; 1991 Feb; 41(2 ( Pt 1)):331-2. PubMed ID: 1992391
    [No Abstract]   [Full Text] [Related]  

  • 6. Amyotrophic lateral sclerosis and paraproteinemia.
    Krieger C; Melmed C
    Neurology; 1982 Aug; 32(8):896-8. PubMed ID: 6808418
    [No Abstract]   [Full Text] [Related]  

  • 7. Motor neuron disease and amyotrophic lateral sclerosis: relation of high CSF protein content to paraproteinemia and clinical syndromes.
    Younger DS; Rowland LP; Latov N; Sherman W; Pesce M; Lange DJ; Trojaborg W; Miller JR; Lovelace RE; Hays AP
    Neurology; 1990 Apr; 40(4):595-9. PubMed ID: 2320231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motor neuron disease and plasma cell dyscrasia.
    Shy ME; Rowland LP; Smith T; Trojaborg W; Latov N; Sherman W; Pesce MA; Lovelace RE; Osserman EF
    Neurology; 1986 Nov; 36(11):1429-36. PubMed ID: 3762961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal gammopathy and motor neuron disease.
    Sadiq SA; Latov N
    Adv Neurol; 1991; 56():413-20. PubMed ID: 1713014
    [No Abstract]   [Full Text] [Related]  

  • 10. A monoclonal IgA in a patient with amyotrophic lateral sclerosis reacts with neurofilaments and surface antigen on neuroblastoma cells.
    Hays AP; Roxas A; Sadiq SA; Vallejos H; D'Agati V; Thomas FP; Torres R; Sherman WH; Bailey-Braxton D; Hays AG
    J Neuropathol Exp Neurol; 1990 Jul; 49(4):383-98. PubMed ID: 2362186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropathy and IgM M-proteins: prognostic value of antibodies to MAG, SGPG, and sulfatide.
    Eurelings M; Moons KG; Notermans NC; Sasker LD; De Jager AE; Wintzen AR; Wokke JH; Van den Berg LH
    Neurology; 2001 Jan; 56(2):228-33. PubMed ID: 11160960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cryoglobulinemia complicated by familial spastic spinal paralysis].
    Sawicka E; Szmidt-Sałkowska E
    Neurol Neurochir Pol; 1980; 14(5):565-9. PubMed ID: 7453931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleocytoplasmic transport in C9orf72-mediated ALS/FTD.
    Zhang K; Grima JC; Rothstein JD; Lloyd TE
    Nucleus; 2016 Apr; 7(2):132-7. PubMed ID: 27116041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic value of autoantibodies to MAG by ELISA Bühlmann in 117 immune-mediated peripheral neuropathies associated with monoclonal IgM to SGPG/SGLPG].
    Caudie C; Kaygisiz F; Jaquet P; Petiot P; Gonnaud PM; Antoine JC; Vial C
    Ann Biol Clin (Paris); 2006; 64(4):353-9. PubMed ID: 16829480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-MAG and anti-SGPG antibodies in neuropathy.
    Van den Berg L; Hays AP; Nobile-Orazio E; Kinsella LJ; Manfredini E; Corbo M; Rosoklija G; Younger DS; Lovelace RE; Trojaborg W; Lange DE; Goldstein S; Delfiner JS; Sadiq SA; Sherman WH; Latov N
    Muscle Nerve; 1996 May; 19(5):637-43. PubMed ID: 8618562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Sulfoglucuronosyl Paragloboside Antibody: A Potential Serologic Marker of Amyotrophic Lateral Sclerosis.
    Li D; Usuki S; Quarles B; Rivner MH; Ariga T; Yu RK
    ASN Neuro; 2016 Oct; 8(5):. PubMed ID: 27683876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphoproliferative disorders and motor neuron disease.
    Leone KV; Phillips LH
    Neurology; 1998 Feb; 50(2):576. PubMed ID: 9484412
    [No Abstract]   [Full Text] [Related]  

  • 18. Amyotrophic lateral sclerosis and lymphoma: bone marrow examination and other diagnostic tests.
    Rowland LP; Sherman WH; Latov N; Lange DJ; McDonald TD; Younger DS; Murphy PL; Hays AP; Knowles D
    Neurology; 1992 May; 42(5):1101-2. PubMed ID: 1579233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between cytomegalovirus infection and IgM anti-MAG/SGPG antibody-associated neuropathy.
    Yuki N; Yamamoto T; Hirata K
    Ann Neurol; 1998 Sep; 44(3):408-10. PubMed ID: 9749612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutrition assessment and management in amyotrophic lateral sclerosis.
    Braun MM; Osecheck M; Joyce NC
    Phys Med Rehabil Clin N Am; 2012 Nov; 23(4):751-71. PubMed ID: 23137736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.